Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Novel PAF antagonist protects eyes against alkali and light-induced damage

May 11, 2004

No Comments

Intravitreal pegaptanib reported safe and effective in ocular neovascularization disorders

May 10, 2004

No Comments

Dose-dependent activity of EGT-001 in ocular angiogenesis model

May 7, 2004

No Comments

Novel somatostatin analogue may be effective in diabetic retinopathy

May 7, 2004

No Comments

Angiocol inhibits retinal angiogenesis in vitro

May 7, 2004

No Comments

Prostaglandin derivative DE-085 increases retinal blood flow

May 6, 2004

No Comments

St. John's wort and hypericin may prevent diabetic and premature retinopathy

May 6, 2004

No Comments

Specific cannabinoid receptor agonist may prevent tissue damage in retina

May 5, 2004

No Comments

Tyrosine kinase inhibitor blocks choroidal neovascularization

May 4, 2004

No Comments

Regression of ocular neovascularization by periocular PEDF gene therapy

May 4, 2004

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Novel PAF antagonist protects eyes against alkali and light-induced damage

Intravitreal pegaptanib reported safe and effective in ocular neovascularization disorders

Dose-dependent activity of EGT-001 in ocular angiogenesis model

Novel somatostatin analogue may be effective in diabetic retinopathy

Angiocol inhibits retinal angiogenesis in vitro

Prostaglandin derivative DE-085 increases retinal blood flow

St. John's wort and hypericin may prevent diabetic and premature retinopathy

Specific cannabinoid receptor agonist may prevent tissue damage in retina

Tyrosine kinase inhibitor blocks choroidal neovascularization

Regression of ocular neovascularization by periocular PEDF gene therapy

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Ocular RSS

Ocular
RSS